Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
With this impressive expected growth, it's no wonder many investors are interested in owning cannabis stocks. What's the best approach to marijuana stock investing? These seven key steps will tell you what you need to know to become a cannabis investor.
There are two broad categories of cannabis products:
The three primary types of companies in the marijuana industry are:
Investing in any type of asset comes with some degree of risk. Investing in marijuana stocks is associated with additional specific risks you should clearly understand:
When considering any marijuana stock, you should:
For marijuana growing companies, specific metrics to research include:
You can look for and prioritize marijuana growers with lower cost structures since they tend to be the most competitive.
Now for the fun part: digging into the top marijuana companies. You may also want to check out marijuana-focused exchange-traded funds (ETFs).
Below is a list of top marijuana stocks to consider thoroughly. Note that this collection isn't comprehensive and includes only marijuana stocks with a market cap of at least $200 million.
Marijuana ETF | Assets Under Management |
---|---|
Amplify Alternative Harvest ETF (NYSEMKT:MJ) | $104 million |
Global X Marijuana Life Sciences Index ETF (OTC:HMLSF) | $45 million |
Investing in marijuana companies is not suitable for everyone. For some, particularly conservative investors, the best approach is to avoid these stocks entirely. Only investors who understand and can tolerate high levels of risk should add cannabis companies to their investment portfolios.
Even for aggressive investors, it's unwise to put too much of your portfolio into any one marijuana stock or ETF. Consider starting with a small position in a marijuana stock and adding to your holdings as the cannabis market grows and the company increases its revenue and earnings.
The investment becomes less risky as your investment thesis is confirmed. However, if the company performs poorly, you should reevaluate your investment assumptions.
When choosing which cannabis stocks to buy, remember that some are arguably safer than others. For example, Scotts Miracle-Gro, which historically sells lawn and garden products, generates much of its revenue outside the cannabis industry. So, the company doesn't face many of the risks normally associated with cannabis products and could be a better choice for more conservative investors.
While investors are generally advised to take a long-term view when buying stocks, the dynamics of the marijuana industry are rapidly changing. The criteria you should use today to make a stock-buying decision could be dramatically different in just a few months.
Marijuana industry investors should closely monitor any marijuana stocks or ETFs in their portfolios, along with the overall industry itself. Some changes -- such as the U.S. federal government relaxing its marijuana laws -- would be beneficial, while others could be devastating.
The global marijuana industry is likely to experience tremendous growth, but it may not occur evenly or predictably. Following these seven steps for investing in marijuana stocks can help investors navigate this exciting and challenging industry.
Global marijuana markets are growing like a weed. The value of the worldwide legal cannabis market is projected to increase by a compound annual growth rate of 34% and to reach $444 billion by 2030, according to Forbes Business Insights.
Here are a couple of marijuana ETFs to also consider adding to your portfolio:
Company name | Company ticker | Market cap | Sector |
---|---|---|---|
Green Thumb Industries | OTC:GTBIF | $2.1 billion | Health Care |
Trulieve Cannabis | OTC:TCNNF | $1.7 billion | Health Care |
Cronos Group | NASDAQ:CRON | $980.3 million | Health Care |
Curaleaf | OTC:CURLF | $2.4 billion | Health Care |
Tilray Brands | NASDAQ:TLRY | $1.5 billion | Health Care |
SNDL | NASDAQ:SNDL | $651.2 million | Health Care |
Canopy Growth | NASDAQ:CGC | $356.5 million | Health Care |
Aurora Cannabis | NASDAQ:ACB | $300.9 million | Health Care |
Jazz Pharmaceuticals Plc | NASDAQ:JAZZ | $7.5 billion | Health Care |
Scotts Miracle-Gro | NYSE:SMG | $3.6 billion | Materials |
Innovative Industrial Properties | NYSE:IIPR | $1.6 billion | Real Estate |
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.